The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

Roche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...

Four-year data: On Wednesday, July 30, as part of the “Developing Topics Session: Innovative Therapeutic Approaches” (8:00 – 8:45 AM EDT ), initial four-year findings will be presented on lecanemab ...

Researchers are exploring cancer drugs as a potential treatment for Alzheimer's disease, a neurodegenerative disorder with limited treatment options. Studies have identified two cancer drugs, ...

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...

We all forget things. Names, dates, phone chargers – even why we walked into the kitchen. It’s called being human… or, let’s be honest, being over 40 in a digital world with too many tabs open in our ...